Design, synthesis and biological evaluation of new series of hexahydroquinoline and fused quinoline derivatives as potent inhibitors of wild-type EGFR and mutant EGFR (L858R and T790M)
Mennatallah A. Shaheen, Ali A. El‐Emam, Nadia S. El‐Gohary
Topics & Concepts
ChemistryCytotoxicityIC50T790MCancer cellErlotinibApoptosisQuinolineKinaseCell culturePharmacologyCell cycle checkpointIn vitroCell cycleBiochemistryCancerEpidermal growth factor receptorBiologyReceptorGefitinibOrganic chemistryGeneticsLung Cancer Treatments and MutationsCancer therapeutics and mechanismsQuinazolinone synthesis and applications